Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) EBITDA Margin (2025)

Historic EBITDA Margin for Coeptis Therapeutics Holdings (COEPW) over the last 1 years, with Q3 2025 value amounting to 1043.22%.

  • Coeptis Therapeutics Holdings' EBITDA Margin changed N/A to 1043.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 2638.23%, marking a year-over-year change of. This contributed to the annual value of 18727.91% for FY2021, which is N/A changed from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' EBITDA Margin stood at 1043.22%.
  • In the past 5 years, Coeptis Therapeutics Holdings' EBITDA Margin ranged from a high of 1043.22% in Q3 2025 and a low of 6452.56% during Q1 2025